Kai Li

Publications

Citations

H-Index

2023

Active since

Affiliations

Chinese Academy of Medical Sciences & Peking Union Medical College(Current)

Anhui Provincial Hospital

Shanghai Chest Hospital

Guangzhou Medical University

Peking University Cancer Hospital

Kai Li is an author at Chinese Academy of Medical Sciences & Peking Union Medical College specializing in molecular oncology, cancer therapeutics, and lung cancer.

Top concepts

MedicineOncologyPathologyLung CancerCancer TherapyMolecular OncologyRadiation Oncology

Publications per year

2023–2024

Publications

First-line penpulimab combined with paclitaxel and carboplatin for metastatic squamous non-small-cell lung cancer in China (AK105-302): a multicentre, randomised, double-blind, placebo-controlled phase 3 clinical trial

Hua Zhong, Shengjie Sun, Jianhua Chen et al. · The Lancet Respiratory Medicine · 2024 · 47 citations

First-line Penpulimab, Placebo-controlled Phase 3, Medicine +8

RETRACTED ARTICLE: Protective role of arachidonic acid against diabetic myocardial ischemic injury: a translational study of pigs, rats, and humans

Yunhui Lv, Kai Li, Shuo Wang et al. · Cardiovascular Diabetology · 2024 · 19 citations · Full text

Efficacy, safety and pharmacokinetics of Unecritinib (TQ-B3101) for patients with ROS1 positive advanced non-small cell lung cancer: a Phase I/II Trial

Shun Lü, Hongming Pan, Lin Wu et al. · Signal Transduction and Targeted Therapy · 2023 · 16 citations · Full text

Rows per page

1–3 of 3